Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ Scribed by John E. Levine; Bruce R. Blazar; Todd DeFor; James L.M. Ferrara; Daniel J. Weisdorf

• Book ID: 116280404
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 160 KB
• Volume: 14
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.06.013